These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33744682)

  • 1. The relationship between cognitive deficits and impaired short-term functional outcome in clinical high-risk for psychosis participants: A machine learning and modelling approach.
    Haining K; Brunner G; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Schizophr Res; 2021 May; 231():24-31. PubMed ID: 33744682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterising cognitive heterogeneity in individuals at clinical high-risk for psychosis: a cluster analysis with clinical and functional outcome prediction.
    Haining K; Gajwani R; Gross J; Gumley AI; Ince RAA; Lawrie SM; Schultze-Lutter F; Schwannauer M; Uhlhaas PJ
    Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):437-448. PubMed ID: 34401957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
    Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
    JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.
    Koutsouleris N; Kambeitz-Ilankovic L; Ruhrmann S; Rosen M; Ruef A; Dwyer DB; Paolini M; Chisholm K; Kambeitz J; Haidl T; Schmidt A; Gillam J; Schultze-Lutter F; Falkai P; Reiser M; Riecher-Rössler A; Upthegrove R; Hietala J; Salokangas RKR; Pantelis C; Meisenzahl E; Wood SJ; Beque D; Brambilla P; Borgwardt S;
    JAMA Psychiatry; 2018 Nov; 75(11):1156-1172. PubMed ID: 30267047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study.
    Guo JY; Niendam TA; Auther AM; Carrión RE; Cornblatt BA; Ragland JD; Adelsheim S; Calkins R; Sale TG; Taylor SF; McFarlane WR; Carter CS
    Psychol Med; 2020 Oct; 50(13):2230-2239. PubMed ID: 31507256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.
    Carrión RE; McLaughlin D; Auther AM; Olsen R; Correll CU; Cornblatt BA
    Psychol Med; 2015 Nov; 45(15):3341-54. PubMed ID: 26169626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological deficits in participants at clinical high risk for psychosis recruited from the community: relationships to functioning and clinical symptoms.
    Haining K; Matrunola C; Mitchell L; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Psychol Med; 2020 Jan; 50(1):77-85. PubMed ID: 30862319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition.
    Staines L; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    BMC Psychiatry; 2021 Jul; 21(1):339. PubMed ID: 34233651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cognitive functioning in the outcome of those at clinical high risk for developing psychosis.
    Addington J; Barbato M
    Epidemiol Psychiatr Sci; 2012 Dec; 21(4):335-42. PubMed ID: 23174394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood Maltreatment and Its Association with Cognitive Ability in Young People Suspected to Be at Clinical High Risk of Psychosis.
    Büetiger JR; Michel C; Kaess M; Kindler J
    Psychopathology; 2023; 56(1-2):17-28. PubMed ID: 35660706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term functional outcome in psychotic patients: results of the Turku early psychosis study (TEPS).
    Salokangas RKR; From T; Ilonen T; Luutonen S; Heinimaa M; Armio RL; Laurikainen H; Walta M; Paju J; Toivonen A; Jalo P; Tuominen L; Hietala J
    BMC Psychiatry; 2021 Dec; 21(1):602. PubMed ID: 34856968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial.
    Susai SR; Mongan D; Healy C; Cannon M; Cagney G; Wynne K; Byrne JF; Markulev C; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Street R; Thompson A; Ruth Yung A; Nelson B; McGorry PD; Föcking M; Paul Amminger G; Cotter D
    Brain Behav Immun; 2022 Jul; 103():50-60. PubMed ID: 35341915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis.
    Dong F; Mao Z; Ding Y; Wang L; Bo Q; Li F; Wang F; Wang C
    Front Psychiatry; 2023; 14():1292141. PubMed ID: 38146278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach.
    Worthington MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Lympus CA; Mathalon DH; Perkins DO; Stone WS; Walker EF; Woods SW; Zhao Y; Cannon TD
    JAMA Psychiatry; 2023 Oct; 80(10):1017-1025. PubMed ID: 37531131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using combined environmental-clinical classification models to predict role functioning outcome in clinical high-risk states for psychosis and recent-onset depression.
    Antonucci LA; Penzel N; Sanfelici R; Pigoni A; Kambeitz-Ilankovic L; Dwyer D; Ruef A; Sen Dong M; Öztürk ÖF; Chisholm K; Haidl T; Rosen M; Ferro A; Pergola G; Andriola I; Blasi G; Ruhrmann S; Schultze-Lutter F; Falkai P; Kambeitz J; Lencer R; Dannlowski U; Upthegrove R; Salokangas RKR; Pantelis C; Meisenzahl E; Wood SJ; Brambilla P; Borgwardt S; Bertolino A; Koutsouleris N;
    Br J Psychiatry; 2022 Feb; ():1-17. PubMed ID: 35152923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: a 3 year longitudinal study.
    Ayesa-Arriola R; Rodríguez-Sánchez JM; Pérez-Iglesias R; González-Blanch C; Pardo-García G; Tabares-Seisdedos R; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2013 Oct; 209(3):302-8. PubMed ID: 23403293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression.
    Koutsouleris N; Dwyer DB; Degenhardt F; Maj C; Urquijo-Castro MF; Sanfelici R; Popovic D; Oeztuerk O; Haas SS; Weiske J; Ruef A; Kambeitz-Ilankovic L; Antonucci LA; Neufang S; Schmidt-Kraepelin C; Ruhrmann S; Penzel N; Kambeitz J; Haidl TK; Rosen M; Chisholm K; Riecher-Rössler A; Egloff L; Schmidt A; Andreou C; Hietala J; Schirmer T; Romer G; Walger P; Franscini M; Traber-Walker N; Schimmelmann BG; Flückiger R; Michel C; Rössler W; Borisov O; Krawitz PM; Heekeren K; Buechler R; Pantelis C; Falkai P; Salokangas RKR; Lencer R; Bertolino A; Borgwardt S; Noethen M; Brambilla P; Wood SJ; Upthegrove R; Schultze-Lutter F; Theodoridou A; Meisenzahl E;
    JAMA Psychiatry; 2021 Feb; 78(2):195-209. PubMed ID: 33263726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
    Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
    J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.